[Marmolade]

Prayer time shortly. 3:15.
Be praying for our country and others.

Therefore there is now no condemnation for those who are in Christ Jesus, because through Christ Jesus the law of the Spirit of life set me free from the law of sin and death.
Rom. 8:1

[numberonepal]

Groundbreaking Global Study on 99 Million Vaccinated People Reveals Increases in Neurological, Blood, and Heart Conditions Associated with COVID-19 Vaccines

Here’s what the study found about how certain health issues showed up after people got their COVID-19 vaccines:

Neurological Conditions:

• After getting the first dose of the Oxford/AstraZeneca vaccine, there was a noticeable increase in Guillain-Barré syndrome (GBS), where the body’s immune system attacks its nerves.
• Acute disseminated encephalomyelitis (ADEM), a rare brain and spinal cord inflammation, also popped up more than expected after the first Moderna vaccine dose.
• Other neurological issues like transverse myelitis (spinal cord inflammation), Bell’s palsy (facial paralysis), and seizures also occurred more than usual after some doses of these vaccines.

Blood Clot and Platelet Conditions:

• The Oxford/AstraZeneca vaccine first dose was linked to more cases of cerebral venous sinus thrombosis (CVST), a type of blood clot in the brain, than expected.
• There were also more instances of low platelet counts and pulmonary embolism (blood clots in the lungs) after some doses of Oxford/AstraZeneca, Pfizer, and Moderna vaccines.
• Some vaccines also led to an increase in splanchnic vein thrombosis (SVT), another type of blood clot, after certain doses, but these findings didn’t signal a major safety concern according to the study’s criteria.

Heart Conditions:

• Cases of myocarditis (heart inflammation) were significantly higher than expected after the first, second, and third doses of mRNA vaccines (like Pfizer and Moderna).
• Pericarditis (inflammation of the heart’s outer layer) cases also exceeded expectations after some doses of the Moderna vaccine and after the third dose of the Oxford/AstraZeneca vaccine.
• These heart-related findings were considered important safety signals that need attention.

Study sawse:

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

This multi-country analysis confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were identified.